V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240000315 | 240000315 | null | null | null | null | 2019-07-16 | null | null | null | AML16 TRIAL | 100305042 |
| 240000326 | 240000326 | null | null | null | null | 2019-03-21 | null | null | null | DA | 100557035 |
| 240000328 | 240000328 | null | null | null | null | 2018-05-18 | CLADRIBINE | null | null | AML18 TRIAL | 101465246 |
| 240000331 | 240000331 | null | null | null | null | 2016-03-26 | Hydroxycarbamide | null | null | AML19 TRIAL | 101422082 |
| 240000338 | 240000338 | null | null | null | null | 2018-12-12 | ALL UKALL2011 IndB Std Dex (PegAsp) | null | null | DA | 100041405 |
| 240000347 | 240000347 | 1.62 | 67.4 | Curative (C) | null | 2018-11-09 | null | 02 | N | HYDROXYCARBAMIDE | 100081506 |
| 240000358 | 240000358 | 1.67 | 62 | Curative (C) | 2019-02-27 | 2019-02-27 | CYTARABINE + DAUNORUBICIN | 02 | N | AML19 TRIAL | 100989663 |
| 240000366 | 240000366 | 1.91 | 75 | 03 | null | 2016-08-21 | Trial Unspecified | 02 | null | AML19 TRIAL | 101794713 |
| 240000373 | 240000373 | 1.79 | 68 | Palliative (P) | 2016-06-04 | 2016-06-06 | CHOP R - 21 days | 02 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 101869272 |
| 240000384 | 240000384 | null | null | null | null | 2017-07-26 | Fludarabine + Melphalan RIC Allo | null | null | AML19 TRIAL | 100584275 |
| 240000386 | 240000386 | null | null | null | null | 2018-05-23 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101145582 |
| 240000395 | 240000395 | 1.78 | 75 | Curative (C) | null | 2019-02-27 | Hydroxycarbamide | Y | N | CABOZANTINIB | 101370261 |
| 240000405 | 240000405 | 0 | 72 | Curative (C) | null | 2017-08-01 | ATG + Busulfan + Fludarabine | 01 | N | AXITINIB | 101780627 |
| 240000417 | 240000417 | 1.86 | 50.6 | Curative (C) | null | 2019-11-24 | CHOP R | Y | N | CLADRIBINE | 100281853 |
| 240000429 | 240000429 | 1.54 | 94.5 | Palliative (P) | 2018-11-13 | 2018-11-19 | null | 02 | null | UKALL14- PH 1 INDUCTION | 100326451 |
| 240000432 | 240000432 | 0 | 86.65 | null | null | 2018-07-27 | null | N | Y | HYDROXYCARBAMIDE | 101512026 |
| 240000445 | 240000445 | 1.77 | 0 | Adjuvant (A) | 2017-01-27 | 2017-01-28 | CHOP R | 02 | N | HYDROXYCARBAMIDE | 101754288 |
| 240000453 | 240000453 | null | null | null | 2018-02-06 | 2018-02-06 | Triple / Double Intrathecal Therapy | 02 | null | HYDROXYCARBAMIDE | 101134864 |
| 240000456 | 240000456 | 1.62 | 71 | Palliative (P) | null | 2019-07-02 | null | N | N | BENDAMUSTINE + RITUXIMAB | 101839245 |
| 240000461 | 240000461 | null | null | null | null | 2019-08-03 | null | null | null | DA | 101077997 |
| 240000468 | 240000468 | null | null | null | null | 2019-08-10 | null | null | null | RITUXIMAB | 101540434 |
| 240000470 | 240000470 | 1.7 | 62 | Palliative (P) | null | 2019-07-31 | FLUOROURACIL + FOLINIC ACID | N | N | HYDROXYCARBAMIDE | 100603795 |
| 240000473 | 240000473 | 1.84 | 56.8 | Disease modification (D) | null | 2016-11-17 | CHOP - 21 days | N | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101773294 |
| 240000478 | 240000478 | 1.65 | 54.9 | Curative (C) | 2017-09-20 | 2017-09-25 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101835218 |
| 240000482 | 240000482 | 1.68 | 45.35 | Curative (C) | null | 2017-10-04 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | AML18 TRIAL | 101043104 |
| 240000486 | 240000486 | 1.68 | 63.8 | Adjuvant (A) | 2017-01-04 | 2017-01-05 | Hydroxycarbamide | Y | N | TRIAL UNSPECIFIED | 100095944 |
| 240000488 | 240000488 | null | null | null | null | 2016-08-22 | Triple / Double Intrathecal Therapy + hydrocortisone | null | null | IMATINIB | 101447616 |
| 240000490 | 240000490 | 1.85 | 34.15 | 03 | null | 2017-03-17 | Imatinib 400mg | 02 | N | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 101592817 |
| 240000492 | 240000492 | 0 | 66.3 | Disease modification (D) | null | 2017-02-20 | null | N | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 100212734 |
| 240000494 | 240000494 | null | null | null | null | 2019-06-12 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100883535 |
| 240000499 | 240000499 | 1.68 | 70 | Curative (C) | null | 2019-10-23 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | HYDROXYCARBAMIDE | 101071444 |
| 240000506 | 240000506 | 1.77 | null | Disease modification (D) | 2016-12-20 | 2016-12-21 | RFluCy RIC | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100084458 |
| 240000507 | 240000507 | 1.62 | 79 | Curative (C) | null | 2018-01-27 | null | 2 | N | RUXOLITINIB | 100916274 |
| 240000508 | 240000508 | 1.67 | 62.9 | Curative (C) | 2017-01-15 | 2017-01-18 | null | 02 | N | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101358537 |
| 240000515 | 240000515 | null | null | null | null | 2017-07-11 | CHOP R - 21 days | null | null | AZACITIDINE | 101607684 |
| 240000528 | 240000528 | 1.63 | 55.8 | 03 | 2019-07-22 | 2019-07-23 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100716578 |
| 240000543 | 240000543 | 0 | 0 | 03 | null | 2017-02-11 | null | 01 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101437171 |
| 240000545 | 240000545 | 1.62 | 65 | 03 | 2019-04-18 | 2019-04-19 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100071322 |
| 240000552 | 240000552 | 1.85 | 65.9 | Curative (C) | 2016-08-22 | 2016-08-23 | null | N | N | AML19 TRIAL | 100139166 |
| 240000572 | 240000572 | null | null | null | null | 2016-07-10 | R CODOX M | null | null | TRIPLE INTRATHECAL | 101610201 |
| 240000575 | 240000575 | null | null | null | null | 2016-07-01 | null | null | null | ALL INT GDE 2019 IND B | 100543120 |
| 240000576 | 240000576 | 1.72 | 62 | Palliative (P) | null | 2016-08-15 | Triple / Double Intrathecal Therapy + hydrocortisone | 02 | N | IBRUTINIB | 100226430 |
| 240000579 | 240000579 | null | null | null | null | 2018-07-19 | null | null | null | HYDROXYCARBAMIDE | 100966051 |
| 240000585 | 240000585 | null | null | null | null | 2017-10-28 | DA | null | null | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 100136164 |
| 240000594 | 240000594 | 1.68 | 69.5 | Curative (C) | 2019-05-26 | 2019-05-31 | null | 01 | N | AML18 TRIAL | 101173382 |
| 240000602 | 240000602 | 1.84 | 91 | Palliative (P) | 2016-04-12 | 2016-04-12 | Mitoxantrone | 02 | N | HYDROXYCARBAMIDE | 101795875 |
| 240000604 | 240000604 | 1.53 | 79.9 | Palliative (P) | null | 2018-02-11 | Hydroxycarbamide | 02 | N | CHOP R | 101585556 |
| 240000609 | 240000609 | 1.68 | 96.7 | Curative (C) | 2016-10-03 | 2016-10-03 | Hydroxycarbamide | 02 | N | AML16 TRIAL | 101591784 |
| 240000614 | 240000614 | 1.78 | 78.3 | 03 | null | 2018-10-29 | null | 2 | N | AML MYECHILD 01 IT CYT | 101002825 |
| 240000615 | 240000615 | null | 70.1 | Curative (C) | null | 2017-07-16 | CHOP R | 02 | N | IMATINIB | 100529667 |